Home / Mepolizumab / Italy
IT ATC R03DX09 · updated 2 Nov 2026
Mepolizumab shortage in Italy
Is there a Mepolizumab shortage in Italy?
Yes. As of 2 Nov 2026, 1 Mepolizumab product is reported short in Italy. The company estimate for the return is 18 Dec 2026. Main reason: manufacturing problem.
Also short in Norway. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | NUCALA anticipated discontinuation | GLAXOSMITHKLINE TRADING SERVICES LIMITED | 25 Nov 2026 | 18 Dec 2026 | Manufacturing problem Problemi produttivi: distribuzione contingentata (carenza relativa solo al canale ospedaliero) |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.